Invention Grant
US07658923B2 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
有权
抗CD26单克隆抗体作为与表达CD26的细胞相关疾病的治疗
- Patent Title: Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
- Patent Title (中): 抗CD26单克隆抗体作为与表达CD26的细胞相关疾病的治疗
-
Application No.: US11676164Application Date: 2007-02-16
-
Publication No.: US07658923B2Publication Date: 2010-02-09
- Inventor: Nam Hoang Dang , Chikao Morimoto , Stuart Schlossman
- Applicant: Nam Hoang Dang , Chikao Morimoto , Stuart Schlossman
- Applicant Address: US TX Austin US MA Boston
- Assignee: Board of Regents, The University of Texas System,Dana-Farber Cancer Institute
- Current Assignee: Board of Regents, The University of Texas System,Dana-Farber Cancer Institute
- Current Assignee Address: US TX Austin US MA Boston
- Agency: Fulbright & Jaworski LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
Therapeutic methods comprising administering anti-CD26 antibodies for the prevention and treatment of cancers and immune diseases associated with expressing CD26 are provided. The invention describes various types of anti-CD26 antibodies and modes of administration.
Public/Granted literature
- US20070207143A1 ANTI-CD26 MONOCLONAL ANTIBODIES AS THERAPY FOR DISEASES ASSOCIATED WITH CELLS EXPRESSING CD26 Public/Granted day:2007-09-06
Information query
